(Q35881049)

English

[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues

scholarly article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues (English)

1 reference

Europe PubMed Central

10 August 2017

1 reference

based on heuristic

inferred from title

author name string

Adam F Prasanphanich

1

1 reference

Europe PubMed Central

10 August 2017

Prasant K Nanda

2

1 reference

Europe PubMed Central

10 August 2017

Tammy L Rold

3

1 reference

Europe PubMed Central

10 August 2017

Lixin Ma

4

1 reference

Europe PubMed Central

10 August 2017

Michael R Lewis

5

1 reference

Europe PubMed Central

10 August 2017

Jered C Garrison

6

1 reference

Europe PubMed Central

10 August 2017

Timothy J Hoffman

7

1 reference

Europe PubMed Central

10 August 2017

Gary L Sieckman

8

1 reference

Europe PubMed Central

10 August 2017

Said D Figueroa

9

1 reference

Europe PubMed Central

10 August 2017

Charles J Smith

10

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

12 July 2007

1 reference

Europe PubMed Central

10 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

10 August 2017

104

1 reference

Europe PubMed Central

10 August 2017

30

1 reference

Europe PubMed Central

10 August 2017

12462-12467

1 reference

Europe PubMed Central

10 August 2017

In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Nuclear medicine studies of the prostate, testes, and bladder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

PET in the management of urologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

In vitro and in vivo evaluation of a 64Cu-labeled polyethylene glycol-bombesin conjugate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Technetium labeled small peptide radiopharmaceuticals in the identification of lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Small peptide radiopharmaceuticals in the imaging of acute thrombus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Peptide radiopharmaceuticals for diagnosis and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Recent progress in fluorine-18 labelled peptide radiopharmaceuticals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Imaging tumors with peptide-based radioligands.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Peptide receptor imaging and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Peptide radiopharmaceuticals in nuclear medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Target to apoptosis: a hopeful weapon for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Second-line treatment of metastatic prostatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Prostate cancer treatment strategies based on tumor-specific biological principles: future directions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

11 July 2018

Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

24 September 2018

Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

24 September 2018

microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

24 September 2018

Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

24 September 2018

MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

24 September 2018

Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of clinically advanced prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

24 September 2018

Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

24 September 2018

Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

24 September 2018

99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

24 September 2018

A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914305

24 September 2018

1,4,7-Triazacyclononane-N,N',N''-triacetate (TCTA), a new hexadentate ligand for divalent and trivalent metal ions. Crystal structures of [CrIII(TCTA)], [FeIII(TCTA)], and Na[CuII(TCTA)].bul.2NaBr.bul.8H2O

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0705347104

21 January 2018

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Is Useless for the Detection of Local Recurrence after Radical Prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17626788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17626788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/17626788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretargeted peptide imaging and therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17626788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17626788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiometal-labeled agents (non-technetium) for diagnostic imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/17626788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17626788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic use of radiolabelled peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/17626788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.0705347104

1 reference

Europe PubMed Central

10 August 2017

2007PNAS..10412462P

0 references

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35881049&oldid=1647487692"